Tower Research Capital LLC (Trc) Oyster Point Pharma, Inc. Transaction History

Tower Research Capital LLC (Trc)

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$7.95 - $11.68 $254,797 - $374,344	-32,050 Reduced 78.34%	8,861 $99,000
Q3 2022 Nov 10, 2022	BUY	$4.41 - $8.38 $167,990 - $319,219	38,093 Added 1351.77%	40,911 $230,000
Q2 2022 Aug 15, 2022	BUY	$3.6 - $11.2 $6,832 - $21,257	1,898 Added 206.3%	2,818 $12,000
Q1 2022 May 12, 2022	SELL	$8.58 - $17.65 $8,348 - $17,173	-973 Reduced 51.4%	920 $11,000
Q4 2021 Feb 14, 2022	BUY	$10.17 - $18.96 $3,406 - $6,351	335 Added 21.5%	1,893 $34,000
Q3 2021 Nov 15, 2021	BUY	$11.67 - $18.07 $2,882 - $4,463	247 Added 18.84%	1,558 $19,000
Q2 2021 Aug 16, 2021	BUY	$16.25 - $21.51 $5,720 - $7,571	352 Added 36.7%	1,311 $23,000
Q1 2021 May 17, 2021	SELL	$17.92 - $25.86 $45,176 - $65,193	-2,521 Reduced 72.44%	959 $18,000
Q4 2020 Feb 16, 2021	SELL	$18.13 - $25.18 $46,594 - $64,712	-2,570 Reduced 42.48%	3,480 $65,000
Q3 2020 Nov 16, 2020	BUY	$17.83 - $29.12 $85,441 - $139,543	4,792 Added 380.92%	6,050 $128,000
Q2 2020 Aug 13, 2020	BUY	$27.86 - $35.93 $35,047 - $45,199	1,258 New	1,258 $36,000
Q1 2020 May 15, 2020	SELL	$23.65 - $40.96 $10,193 - $17,653	-431 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$13.55 - $26.15 $5,840 - $11,270	431 New	431 $11,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.